Normal and cancer stem cells of the human female reproductive system

Reproductive Biology and Endocrinology

Volumn 11, Issue 1, 2013, Pages

  López, Jacqueline ^a   Valdez Morales, Francisco J ^a   Benítez Bribiesca, Luis ^b   Cerbón, Marco ^a   Carrancá, Alejandro García ^a,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL DE ONCOLOGÍA   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Cancer stem cells; Female; Human; Reproductive biology; Stem cells

Indexed keywords

BIOLOGICAL MARKER;

CANCER STEM CELL; CELL DIFFERENTIATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; EPITHELIUM CELL; FEMALE GENITAL SYSTEM; GENE MUTATION; HOMEOSTASIS; HUMAN; MESENCHYMAL STEM CELL; MYOMETRIUM; NONHUMAN; OVARY CARCINOMA; PROGENY; REVIEW; STROMA CELL; UTERINE CERVIX CARCINOMA; UTERUS CANCER;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITALIA, FEMALE; HUMANS; NEOPLASTIC STEM CELLS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84879046940     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-11-53     Document Type: Review

References (34)

1. Honda A, Hirose M, Hara K, Matoba S, Inoue K, Miki H, Hiura H, Kanatsu-Shinohara M, Kanai Y, Kono T, et al. Isolation, characterization, and in vitro and in vivo differentiation of putative thecal stem cells. Proc Natl Acad Sci USA 2007, 104:12389-12394. 10.1073/pnas.0703787104, 1941479, 17636128.
2. Szotek PP, Chang HL, Brennand K, Fujino A, Pieretti-Vanmarcke R, Lo Celso C, Dombkowski D, Preffer F, Cohen KS, Teixeira J, Donahoe PK. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc Natl Acad Sci USA 2008, 105:12469-12473. 10.1073/pnas.0805012105, 2527935, 18711140.
3. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005, 65:3025-3029.
4. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008, 68:4311-4320. 10.1158/0008-5472.CAN-08-0364, 2553722, 18519691.
5. Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009, 27:2875-2883.
6. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009, 28:209-218. 10.1038/onc.2008.374, 18836486.
7. Ferrandina G, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella S, Paglia A, et al. Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 2008, 18:506-514. 10.1111/j.1525-1438.2007.01056.x, 17868344.
8. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, Mor G. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 2009, 8:158-166. 10.4161/cc.8.1.7533, 3041590, 19158483.
9. Kusumbe AP, Mali AM, Bapat SA. CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 2009, 27:498-508. 10.1634/stemcells.2008-0868, 19253934.
10. Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, et al. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer 2012, 130:29-39. 10.1002/ijc.25967, 3164893, 21480217.
11. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 2011, 71:3991-4001. 10.1158/0008-5472.CAN-10-3175, 3107359, 21498635.
12. Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 2012, 460:237-249. 10.1007/s00428-012-1203-5, 22322322.
13. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 2004, 70:1738-1750. 10.1095/biolreprod.103.024109, 14766732.
14. Schwab KE, Chan RW, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertil Steril 2005, 84(Suppl 2):1124-1130.
15. Gargett CE. Identification and characterisation of human endometrial stem/progenitor cells. Aust N Z J Obstet Gynaecol 2006, 46:250-253. 10.1111/j.1479-828X.2006.00582.x, 16704483.
16. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 2009, 80:1136-1145. 10.1095/biolreprod.108.075226, 2849811, 19228591.
17. Dimitrov R, Timeva T, Kyurkchiev D, Stamenova M, Shterev A, Kostova P, Zlatkov V, Kehayov I, Kyurkchiev S. Characterization of clonogenic stromal cells isolated from human endometrium. Reproduction 2008, 135:551-558. 10.1530/REP-07-0428, 18367513.
18. Schuring AN, Schulte N, Kelsch R, Ropke A, Kiesel L, Gotte M. Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics. Fertil Steril 2011, 95:423-426. 10.1016/j.fertnstert.2010.08.035, 20864098.
19. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 2007, 22:2903-2911. 10.1093/humrep/dem265, 17872908.
20. Schwab KE, Hutchinson P, Gargett CE. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod 2008, 23:934-943. 10.1093/humrep/den051, 18305000.
21. Masuda H, Matsuzaki Y, Hiratsu E, Ono M, Nagashima T, Kajitani T, Arase T, Oda H, Uchida H, Asada H, et al. Stem cell-like properties of the endometrial side population: implication in endometrial regeneration. PLoS One 2010, 5:e10387. 10.1371/journal.pone.0010387, 2860997, 20442847.
22. Ono M, Maruyama T, Masuda H, Kajitani T, Nagashima T, Arase T, Ito M, Ohta K, Uchida H, Asada H, et al. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci USA 2007, 104:18700-18705. 10.1073/pnas.0704472104, 2141840, 18003928.
23. Gorai I, Yanagibashi T, Taki A, Udagawa K, Miyagi E, Nakazawa T, Hirahara F, Nagashima Y, Minaguchi H. Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. Int J Cancer 1997, 72:821-827. 10.1002/(SICI)1097-0215(19970904)72:5<821::AID-IJC19>3.0.CO;2-B, 9311600.
24. Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res 2009, 69:8241-8248. 10.1158/0008-5472.CAN-08-4808, 19843861.
25. Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, Scadden DT, Seiden MV, Foster R, Rueda BR. Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 2008, 7:242-249. 10.4161/cc.7.2.5207, 18256549.
26. Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Kato K, et al. Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol 2010, 176:381-392. 10.2353/ajpath.2010.090056, 2797898, 20008133.
27. Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, et al. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 2009, 15:4299-4311. 10.1158/1078-0432.CCR-08-1883, 19509143.
28. Hill EK, Dizon DS. Medical therapy of endometrial cancer: current status and promising novel treatments. Drugs 2012, 72:705-713. 10.2165/11631840-000000000-00000, 22439671.
29. Narayan G, Murty VV. Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis. Future Oncol 2010, 6:1643-1652. 10.2217/fon.10.114, 3037979, 21062161.
30. Ye F, Zhou C, Cheng Q, Shen J, Chen H. Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 2008, 8:108-112. 10.1186/1471-2407-8-108, 2387168, 18419830.
31. Cantz T, Key G, Bleidissel M, Gentile L, Han DW, Brenne A, Schöler HR. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008, 26:692-697. 10.1634/stemcells.2007-0657, 18032701.
32. Lopez J, Poitevin A, Mendoza-Martinez V, Perez-Plasencia C, Garcia-Carranca A. Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance. BMC Cancer 2012, 12:48. 10.1186/1471-2407-12-48, 3299592, 22284662.
33. Li J, Zhou B. Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011, 11:49. 10.1186/1471-2407-11-49, 3040162, 21284870.
34. Gu W, Yeo E, McMillan N, Yu C. Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer Gene Ther 2011, 18:897-905. 10.1038/cgt.2011.58, 21904396.